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The medial prefrontal cortex (mPFC) modulates a range of behaviors, including responses to 
noxious stimuli. While various pain modalities alter mPFC function, our understanding of changes 
to specific cell types underlying pain-induced mPFC dysfunction remains incomplete. Proper 
activity of cortical GABAergic interneurons is essential for normal circuit function. We find that 
nerve injury increases excitability of layer 5 parvalbumin-expressing neurons in the prelimbic (PL) 
region of the mPFC from male, but not female, mice. Conversely, nerve injury dampens 
excitability in somatostatin-expressing neurons in layer 2/3 of the PL region; however, effects are 
differential between males and females. Nerve injury slightly increases the frequency of 
spontaneous excitatory post-synaptic currents (sEPSCs) in layer 5 parvalbumin-expressing 
neurons in males but reduces frequency of sEPSCs in layer 2/3 somatostatin-expressing neurons in 
females. Our findings provide key insight into how nerve injury drives maladaptive and sex-
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Jones and Sheets show that a nerve injury model of chronic pain produces distinct changes to 
separate, but major, subclasses of GABAergic neurons in the prelimbic cortex. These changes are 
different between male and female mice and provide insight into how chronic pain alters brain 
circuits in a sex-specific manner.
INTRODUCTION
Inhibitory interneurons are essential for normal activity of cortical microcircuits. Given their 
sparse expression in the cortex (~20%–30%), minor alterations to their function are believed 
to drive significant changes to circuit activity. Numerous pain studies report structural and 
functional alterations to the medial prefrontal cortex (mPFC), a region implicated in 
affective and cognitive disturbances associated with chronic pain (Cardoso-Cruz et al., 2013; 
Cheriyan and Sheets, 2018; Huang et al., 2019; Ji et al., 2010; Kelly et al., 2016; Lee et al., 
2015; Metz et al., 2009; Millecamps et al., 2007; Mitrić et al., 2019; Shiers et al., 2018; 
Zhang et al., 2015). Aspects of cellular and circuit mechanisms underlying these 
disturbances have emerged. For instance, cognitive deficits elicited by arthritic pain are 
associated with increased polysynaptic inhibition of layer 5 (L5) pyramidal neurons in the 
prelimbic (PL) region of the mPFC (Ji et al., 2010; Sun and Neugebauer, 2011). A 
subsequent study corroborated this finding by showing that nerve injury increases excitatory 
input to parvalbumin-positive inhibitory neurons (PVINs) in the PL cortex, consequentially 
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decreasing the excitability of L5 pyramidal neurons (Zhang et al., 2015). This implies that 
chronic pain evokes an imbalance in inhibition/excitation in the PL cortex. Indeed, our lab 
has shown that the chronic constriction injury model of neuropathic pain enhances the 
inhibitory-excitatory balance of local inputs onto PL pyramidal neurons that project to the 
periaqueductal gray (PAG), a key structure in the descending analgesic system (Cheriyan 
and Sheets, 2018). A recent study demonstrated that glutamatergic basolateral amygdala 
(BLA) inputs onto PL PVINs are enhanced after chronic nerve injury (Huang et al., 2019). 
Collectively, these results provide compelling evidence for a pain circuit in which nerve 
injury increases the excitation of PL PVINs, which subsequently attenuate normal output of 
neighboring pyramidal neurons targeting subcortical structures involved in pain modulation 
(i.e., PAG). However, important questions remain regarding the impact of nerve injury 
between subclasses of inhibitory neurons across different lamina in distinct regions of the 
mPFC.
In the mPFC, PVINs are active throughout working memory (WM) trials on a delayed non-
match-to-place task, except for the reward period when they are strongly suppressed (Kim et 
al., 2016). Disruption of GABAergic signaling in the mPFC drives deficits in WM and 
cognitive flexibility (Abbas et al., 2018; Bañuelos et al., 2014; Enomoto et al., 2011; Murray 
et al., 2015; Yu et al., 2019), which are deficits commonly comorbid with chronic pain (Dick 
and Rashiq, 2007; Povedano et al., 2007; Ryan et al., 1993; Schiltenwolf et al., 2014). 
Conversely, another class of cortical inhibitory neurons, somatostatin-expressing (SOM) 
interneurons, exhibit phasic activity during the delay period of the same task with no change 
from baseline during the reward period (Kim et al., 2016). Therefore, changes to the 
excitability of PVINs or SOM neurons in the mPFC are poised to be a critical factor in 
cognitive deficits associated with chronic pain. To date, electrophysiological analyses of 
mPFC PVINs or SOM neurons in a model of chronic pain have not been performed.
Traditionally, pain research has focused primarily on males, but it is clear that sex 
differences in pain exist (Mogil, 2012; Mogil and Bailey, 2010). It remains unknown 
whether pain-induced alterations to mPFC circuits are sexually dimorphic. Both women and 
female rodents demonstrate greater sensitivity to painful stimuli than males (Fillingim et al., 
2009; Vacca et al., 2014). Additionally, chronic pain drives sexually dimorphic cognitive 
dysfunction, with male mice showing more significant deficits in set-shifting tasks post-
injury than female mice (Shiers et al., 2018). However, functional alterations to defined 
mPFC GABAergic neurons in male and female mice in neuropathic pain models remain 
unclear. Here, we used transgenic breeding strategies to identify either PVINs or SOM 
neurons in both male and female mice. Our goal was to measure changes to the excitability 
of PVINs and SOM neurons in PL and infralimbic (IL) regions of the mPFC in the spared 
nerve injury (SNI) model of neuropathic pain.
RESULTS
SNI Sensitizes PL PVINs Only in L5 of Male Mice
We observed significant mechanical allodynia in both male and female PVIN-tdTomato 
transgenic mice at post-operative day (POD) 7 following SNI compared to that in sham mice 
(Figure 1A). Mechanical allodynia between male and female mice did not significantly 
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differ (Figure 1A). Following behavioral assessments, we measured the firing properties of 
fluorescently labeled PVINs in the PL cortex of sham and SNI animals using whole-cell 
electrophysiology in acute brain slices (Figures 1B and 1C). Recordings revealed that sham 
female PVINs have significantly higher firing frequency compared to that of sham male 
PVINs, which manifested as greater action potential (AP) firing in response to depolarizing 
step currents (Figures 1D and 1E; Table S1). Because PVINs are expressed diffusely 
throughout the lamina of the mPFC (Figure 1B), we examined changes to PVINs as a 
function of the precise position of the soma along the radial axis of the PL region. Analysis 
of all sham PVINs recorded revealed that female PVINs had a significantly greater input 
resistance than male PVINs (Figure 1F; Table S1). However, this disparity was driven by the 
significant difference in input resistance between L5 PVINs (Figure 1F; Table S1). Our 
recording data revealed that SNI enhanced excitability of PVINs in the PL cortex of male 
mice (Figures 1G and 1H; Table S2). Laminar analysis showed that SNI significantly 
increased input resistance only in L5 PVINs (Figure 1I; Table S3). We did not detect any 
significant differences in the excitability of PVINs between sham and SNI female mice 
(Figures 1J–1L; Table S2). Together, these data indicate that 7–8 days following SNI, PVINs 
in a specific lamina of PL cortex are sensitized in male, but not female, mice.
SNI Increases Frequency of Synaptic Input to L5 PL PVINs Only in Male Mice
We next recorded spontaneous excitatory post-synaptic currents (sEPSCs) from L5 PVINs in 
the PL cortex from male and female mice. We found that frequency, but not amplitude, of 
sEPSCs was significantly greater in female PL PVINs (Figures 2A–2D; Table S4). To assess 
potential changes to synaptic activity driven by nerve injury, we next recorded sEPSCs from 
PVINs in the PL cortex from male sham and SNI mice (Figure 2E; Table S4). We found that 
SNI increased sEPSC frequency recorded in L5 PVINs of male mice but did not change 
sEPSC amplitude (Figure 2F; Table S4). While the increase in sEPSC frequency was not 
significant (t(22) = 1.58, p = 0.06, Student’s unpaired t test), it is consistent with findings of 
a previous study in male mice showing significantly increased sEPSC frequency in PL 
PVINs recorded 10 days after SNI (Zhang et al., 2015). Plots of mean cumulative 
distribution curves revealed an enhanced probability for shorter inter-EPSC intervals in L5 
PVINs from male SNI mice (Figure 2G; Table S4). Mean cumulative distribution curves for 
sEPSC amplitude showed no noticeable differences (Figure 2H; Table S4). We observed no 
significant differences in the frequency or amplitude of sEPSCs recorded in L5 PVINs from 
female sham and SNI mice (Figures 2I–2L; Table S4).
SNI Reduces Input Resistance of PL-SOM Neurons Only in Layer 2/3 of Female Mice
Both male and female SOM-tdTomato transgenic mice at POD7 following SNI displayed 
significant mechanical allodynia compared to sham mice (Figure 3A; Table S3). As in 
PVIN-tdTomato mice, mechanical allodynia measures between male and female mice did 
not significantly differ (Figure 3A; Table S3). In contrast to PVINs, recordings from 
fluorescently labeled SOM neurons in the PL cortex (Figures 3B and 3C; Table S3) revealed 
no significant differences in AP firing or input resistance between female and male mice 
(Figures 3D–3F; Table S3). Recordings showed no significant differences in the excitability 
of SOM neurons from SNI male mice (Figures 3G and 3H; Table S3). However, we found 
that input resistance was not statistically different between male sham and SNI SOM 
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neurons (Figure 3I; Table S3). We found that AP firing in SOM neurons from female sham 
and SNI mice did not differ, but we observed a decreased input resistance in layer 2/3 (L2/3) 
SOM neurons from SNI mice (Figures 3J–3L; Table S3).
SNI Significantly Reduces Frequency of sEPSCs in L2/3 PL-SOM Neurons of Female Mice
To assess SNI-induced changes in synaptic activity, we recorded sEPSCs from layer 2/3 of 
the PL cortex in SOM male and female mice. We found that neither the frequency nor the 
amplitude of sEPSCs from SOM neurons differed between male and female mice (Figures 
4A–4D; Table S4). We also found that SNI did not alter amplitude or frequency of sEPSCs 
in male mice (Figures 4E–4G; Table S4). Mean cumulative distribution curves for amplitude 
and inter-EPSC intervals were also similar (Figure 4H; Table S4). Contrary to those in 
males, L2/3 SOM neurons from female SNI mice demonstrated significantly reduced sEPSC 
frequency and noticeable differences in the mean cumulative distribution curves for inter-
EPSC intervals compared to sham mice (Figures 4I–4L; Table S4). However, no differences 
in amplitude of sEPSCs from L2/3 SOM neurons were detected between female SNI and 
sham mice (Figures 4I–4L; Table S4).
SNI Does Not Alter Excitability of Either PVINs or SOM Neurons in IL Cortex
Our previous work shows that sciatic nerve injury decreases the excitability of L5 pyramidal 
neurons in the PL, but not the IL, region of the mPFC (Cheriyan and Sheets, 2018). 
Therefore, we tested whether SNI altered the firing frequencies of PVINs and SOM neurons 
in the IL cortex again using whole-cell electrophysiology in acute brain slices. We found that 
L2/3 IL-SOM neurons fired fewer APs in female sham mice compared to sham males (U = 
13.5, n1 = 7, n2 = 10, p = 0.03) and that SNI reduced the AP height of L2/3 IL-SOM neurons 
in female SNI mice compared to sham (t(13) = 2.51, p = 0.03; data not shown). Therefore, 
SNI does not significantly alter the intrinsic profile of either PVINs or SOM+ neurons in the 
IL cortex at POD7–POD8.
DISCUSSION
Our data indicate that SNI leading to neuropathic pain behavior evokes changes to mPFC 
inhibitory neurons not only in a sub-type-specific manner (PVINs versus SOM neurons) but 
also in a regional, laminar-specific, and sex-specific manner. Disparities in SNI-induced 
changes between PVINs and SOM neurons have implications for distinct changes to mPFC 
inhibition based on the local targeting of these two major subtypes of inhibitory neurons. In 
other cortical regions, PVINs target soma and basal dendrites of intralaminar cortical 
pyramidal neurons, thereby altering AP output (Markram et al., 2004; Marlin and Carter, 
2014). Therefore, our data indicate that SNI-evoked hyperexcitability of L5 PVINs in male 
mice dampens L5 pyramidal neuron output, consistent with previous findings (Zhang et al., 
2015). Indeed, we have found that chronic constriction of the sciatic nerve enhances 
excitation of L5, but not L2/3, PVINs stimulated with uncaged glutamate (Cheriyan and 
Sheets, 2018). Explanations for why the sensitization of PVINs is specific to L5 following 
nerve injury have yet to emerge. Previous findings indicate that nerve injury elicits 
hyperactivity of ascending BLA inputs, which drives increased feed-forward inhibition of L5 
pyramidal neurons in the PL cortex (Ji et al., 2010; Zhang et al., 2015). Additionally, one 
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study showed that targeting of BLA is strongest to PVINs compared to SOM and pyramidal 
neurons in the mPFC (McGarry and Carter, 2016). This suggests that SNI sensitization of 
BLA-mPFC inputs has the greatest impact on PVIN activity, but preferential targeting of 
BLA to L5 versus L2/3 PVINs remains unknown.
Local inputs from SOM neurons, also known as Martinotti cells (Kawaguchi and Kubota, 
1996, 1997; Wang et al., 2004), target both basal and apical dendrites of cortical pyramidal 
neurons (Fino and Yuste, 2011; Gupta et al., 2000; Kawaguchi and Kubota, 1997; Marlin 
and Carter, 2014). Inhibition targeted to dendrites regulates the probability and wider timing 
window for dendritic events (Kim et al., 1995), including Ca2+ influx, Ca2+ APs, and 
NMDA spikes (Doron et al., 2017; Hayama et al., 2013; Larkum et al., 2001; Marlin and 
Carter, 2014). Inhibition of L2/3 SOM neurons increases both dendritic excitability and burst 
firing of excitatory pyramidal neurons in somatosensory cortex (Gentet et al., 2012). Here, 
we show that SNI reduced synaptic excitability and input resistance of L2/3 SOM neurons in 
female mice. This suggests that neuropathic pain may enhance the excitability of PL 
pyramidal neurons in female mice via reduced L2/3 SOM activity. Why attenuated sEPSC 
frequency and input resistance are observed only in the L2/3 neurons of female, but not 
male, SNI mice remains unresolved. Why SNI drives the hypoexcitability of SOM neurons 
and hyperexcitability of PVINs in the PL cortex is also unclear. PVINs target SOM neurons 
in the somatosensory cortex (Walker et al., 2016), which suggests that the hypoexcitability 
of the PL-SOM neurons from SNI mice may be driven, at least in part, by enhanced local 
inhibitory inputs from hyperexcitable PVINs.
Previous work shows that the local input strength of PVINs and SOM neurons onto cortical 
pyramidal neurons differs based on projection target (Lee et al., 2014; McGarry and Carter, 
2016; Rock and Apicella, 2015). In the mPFC, PVINs preferentially target subcortically 
projecting pyramidal neurons defined by thick-tufted apical dendrites and robust expression 
of h-current (Lee et al., 2014). We have shown that PL neurons with subcortical projections 
to the PAG are hypoexcitable following chronic constriction injury (CCI) of the sciatic nerve 
in male mice (Cheriyan and Sheets, 2018). Based on our present data, this suggests that SNI 
sensitizes PVINs in male mice, which are preferentially targeting PAG-projecting PL 
neurons and dampening their excitability. In fact, a recent study showed that nerve injury 
augments feed-forward inhibition of mPFC output to the PAG (Huang et al., 2019). Because 
SNI had no effect on PL PVIN excitability in female mice, it is likely that SNI also does not 
dampen PL output to the PAG in female mice. Recent work supports this notion by showing 
that nerve injury does not alter AP firing in L5 pyramidal neurons in the mPFC of female 
mice (Gadotti et al., 2019).
The effects of SNI on PVINs in mPFC may underlie specific aspects of cognitive 
dysfunction associated with chronic pain. The activity of PVINs drives cortical gamma 
frequency in the cortex (Lewis et al., 2012; Sohal et al., 2009), which is associated with WM 
in humans (Howard et al., 2003). Reduced function of PVINs is implicated in impaired 
cognition driven by attenuated gamma oscillations in cortical activity (Lewis et al., 2012). 
Although our data indicate an enhanced function of PVINs after SNI, increased excitability 
of PVINs indicates a shift in excitation-inhibition balance, which likely alters the prevalence 
of cortical gamma frequency associated with cognitive control. Indeed, gamma oscillations 
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in the PFC are positively associated with both chronicity and severity of pain in back pain 
patients (May et al., 2019). Cognitive control, or executive control, is defined as flexible 
adaptation of mental resources in order to achieve a particular goal and includes behaviors 
such as attention, decision making, and memory (Mackie et al., 2013). These cognitive 
behaviors are impaired in rodent models of chronic pain (Leite-Almeida et al., 2009; Low et 
al., 2012; Shiers et al., 2018). A recent report showed impaired set-shifting, a test of 
cognitive flexibility, in male, but not female, injured mice (Shiers et al., 2018). While 
cellular mechanisms underlying sexually dimorphic cognitive deficits associated with 
chronic pain remain unresolved, our present data showing increased AP firing in PL PVINs 
from male, but not female, SNI mice provide new insight into sex-specific changes within 
cortical circuits implicated in executive control.
Our results showing that SNI does not alter the excitability of PVINs or SOM neurons in the 
IL region of the mPFC are consistent with studies showing that IL pyramidal neurons are 
unchanged in chronic pain models (Cheriyan and Sheets, 2018; Mitrić et al., 2019). 
However, this result is also intriguing given previous findings in other pain models. In a 
model of arthritic pain, inhibition of IL pyramidal neurons is enhanced due to a reduction in 
retrograde endocannabinoid depression of presynaptic inhibitory inputs (Kiritoshi et al., 
2016). However, there is evidence that cannabinoid receptors 1 (CB1s) are not expressed in 
PVINs (Speed et al., 2015; Wedzony and Chocyk, 2009) but are detected in SOM neurons 
within the somatosensory cortex (Hill et al., 2007). Expression of CB1s in SOM neurons 
within mPFC has yet to be delineated. Therefore, our reported lack of SNI-induced changes 
to IL PVINs and IL-SOM neurons may reflect an absence of CB1 expression in these 
neurons. Studies report CB1 expression on cholecystokinin (CCK)-expressing interneurons 
in hippocampus and somatosensory cortex (Bodor et al., 2005; Tsou et al., 1999); however, 
functional studies of mPFC-CCK+ neurons have not been explored in any pain model. 
Reduced PV expression and shorter axon initial segments are observed in L5/6 IL neurons of 
male mice 3 weeks following SNI (Shiers et al., 2018), which suggests that our recordings 
7–8 days after SNI may be too early to detect significant changes to IL PVINs and IL-SOM 
neurons. Nonetheless, consistent with our present findings in the PL region, this same study 
shows that SNI-induced alterations to IL neurons were specific to male mice (Shiers et al., 
2018).
Overall, our data show complex and differential changes to mPFC inhibitory neurons of 
male and female mice in the SNI model of neuropathic pain. We hope that this research will 
update our knowledge of brain permutations associated with chronic pain so as to lead to 
more targeted pharmacotherapeutic strategies for cognitive deficits between male and female 
pain patients. Next steps will involve optogenetic or chemogenetic stimulation of SOM 
neurons and PVINs in the PL region of male and female SNI mice during measurements of 
cognitive flexibility and anxiety behaviors. These experiments will provide key insight into 
the role of specific inhibitory neuron subclasses in various disorders comorbid with chronic 
pain.
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Lead Contact—Further information and requests for resources and reagents should be 
directed to, and will be fulfilled by, the Lead Contact, Patrick L. Sheets (plsheets@iu.edu).
Materials Availability—This study did not generate new unique reagents.
Data and Code Availability—The datasets supporting the current study have not been 
deposited in a public repository because all data collected are included in the study. Data are 
available from the Lead Contact upon reasonable request.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All experiments were approved by the Indiana University School of Medicine Animal Care 
and Use Committee (protocol number 11234) and adhered to the animal welfare guidelines 
of the National Institutes of Health. Transgenic mice expressing the red fluorescent protein 
TdTomato in cortical neurons expressing somatostatin or parvalbumin were obtained by 
mating female SST-IRES-Cre (SST < tm2.1(cre)Zjh > /J; stock #013044; Jackson Labs; 
(Taniguchi et al., 2011) or PV-IRES-Cre (B6;129P2-Pvalbtm1(cre)Arbr/J;stock #008069; 
Jackson Labs; (Hippenmeyer et al., 2005) mice with male Ai14 (B6.Cg-
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J; stock #007914;Jackson Labs; (Madisen et al., 2010) 
mice. Using immunohistochemistry, an overlap rate of PVIN with SOM+, and vice versa, of 
2%–6% was identified; however, electrophysiological signatures for each cell type have 
been identified (Hu et al., 2013; Nassar et al., 2015). Further inclusion/exclusion criteria is 
detailed in the electrophysiology subsection of the methods. Female and male SOM (n = 65; 
33 males and 32 females) and PVIN mice (n = 61; 30 males and 31 females) aged 36–60 
days and weighing 15–22 g were kept on a 24-hour light/dark cycle (lights on 7AM and off 
7PM) and fed ad libitum for the duration of the experiments. All behavioral experiments and 
surgeries were conducted during the light phase (typically 7 am- 10am). Mice were group 
housed until after the SNI surgery, after which time they were single-housed to prevent 
possible development of empathic responses to pain in sham animals and to reduce the 
incidence of wound reopening.
METHOD DETAILS
Spared Nerve Injury (SNI) Model—Mice were typically tested in groups of 2. For each 
group, the experimenter was blinded to the baseline von Frey results and randomly selected 
one mouse to be SNI and one to be sham. Mice were weighed and briefly anesthetized in an 
anesthesia box with 1.5%–2.5% isoflurane in 100% O2 at a flow rate of 0.8–1.0 L/min 
(SurgiVet Isotech 4, Smith). The snout of the mouse was then placed into a flexible nose 
cone (Vetamac, Rossville, IN) connected to the isoflurane vaporizer allowing for continued 
anesthesia. Body temperature was maintained at 37°C using a feedback-controlled heating 
pad (FHC; Bowdoin, ME).The lateral surface of the left hind leg was shaved and disinfected 
using betadine and isopropyl alcohol. An approximately 4 mm incision through the skin was 
made and the underlying muscle layers were separated by blunt dissection using saline 
moistened sterile wooden dowels. The trifurcation of the left sciatic nerve was visualized. 
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For SNI mice, an approximately 2 mm section of the tibial and common peroneal nerves 
distal to the trifurcation was removed, leaving the sural nerve intact. For sham mice, the 
trifurcation was exposed and visualized but not manipulated. The muscle layers of both SNI 
and sham mice were replaced and the outer skin layers were glued together using Vetbond 
(3M, MN). Approximately half of the mice were given a subcutaneous injection of 
meloxicam (1mg/kg) immediately after closing the incision. We found that meloxicam did 
not affect the development of allodynia. All mice recovered in a clean home cage with ad 
libitum water and wet feed on a heat pad for at least 30 min prior to being returned to the 
vivarium. Mice were monitored 4 days post-operation for signs of excessive pain such as 
reduced eating, drinking, activity or grooming.
Pain Assessment—Following surgery, the experimenter was blinded to SNI and sham 
groups. These animals were randomly assigned a number one or two and the animal 
assigned number one was always tested first by the blinded experimenter. The behavior 
testing apparatus was an elevated wire-mesh platform that held 4-inch wide, 4.5 inch long 
and 4.5-inch tall glass cubicles. On testing days, mice acclimated to the apparatus for 30–60 
min prior to testing. Assessment of mechanical allodynia via paw-withdrawal threshold 
(PWT) was performed using von Frey filaments (Touch Test Sensory Evaluator, North Coast 
Medical Inc., Morgan Hills, CA) in combination with the up-down method to quantify the 
responses at 50% gram force (Bonin et al., 2014; Chaplan et al., 1994). PWTs were 
measured at baseline (prior to SNI or sham surgery), and at postoperative day 7 (POD7). The 
experimenter was blinded to the surgical group of the mice throughout the duration of the 
experiment. Mice that were outliers as determined by the ROUT method with Q = 1 were 
excluded from further analysis. This included 2 SNI and 1 sham from the PV-tdTomato mice 
and 2 SNI and 2 sham from the SOM-tdTomato mice.
Slice Preparation—Mice were euthanized on either POD7 or POD8 for subsequent 
recordings. For both sham and SNI groups, mice were briefly (~15–20s) anesthetized with 
isoflurane and decapitated Brains were rapidly dissected and placed in ice-cold carbogenated 
choline (in mM-25 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 0.5 CaCl2, 7 MgCl2, 25 D-glucose, 
110 C5H14ClNO, 11.60 C6H7NaO6, 3.09 C3H3NaO3) for sectioning. Three hundred 
micrometer thick coronal slices containing mPFC were prepared using a VT1200s Leica 
Vibratome and transferred to artificial cerebrospinal fluid (ACSF) solution (in mM- 127 
NaCl, 25 NaHCO3, 1,25 NaH2PO4, 2.5 KCl, 25 D-glucose, 2 CaCl, 1 MgCl) for 30 min at 
37°C then at room temperature until recording.
Electrophysiology—Recordings in the mPFC contralateral to injury took place on POD7 
or POD8.Borosilicate glass pipettes were fabricated using a horizontal puller (P-97 Sutter) to 
have series resistances between 2 and 5 MΩ and pipette capacitance was compensated. A 
cesium-based internal was used for sEPSC in SOM mice (in mM- cesium methanesulfonate, 
10 HEPES, 10 sodium phosphocreatine, 4 magnesium chloride, 4 sodium ATP, 0.4 sodium 
GTP, 3 ascorbic acid, 1 EGTA, 0.5 QX-314) while a potassium-based internal solution was 
used for all other recordings including sEPSC in PVINs (in mM- 128 K-gluconate, 10 
HEPES, 10 sodium phosphocreatine, 4 magnesium chloride, 4 sodium ATP, 0.4 sodium 
GTP, 3 ascorbic acid, 1 EGTA, and ~4mg/ml biocytin). We found that K-internal solution 
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allowed for more stable recordings in PVINs. Recordings targeted labeled neurons 50–80 
μm deep within in the slice. Series resistance for each neuron was recorded in voltage clamp 
mode. It was not compensated but was required to be < 35 MU for inclusion in the analysis. 
Neuronal properties were recorded in current-clamp mode at resting membrane potential 
except for voltage sag. Voltage sag was measured from a membrane potential of −70 ± 3 mV 
by presenting multiple one second hyperpolarizing current steps (−200 pA, −150 pA, −100 
pA, −50 pA). Percentage voltage sag was calculated using the peak voltage (Vpeak) and 
steady-state voltage (Vss) using the Equation 100 × (Vpeak–Vss)/Vpeak. Input resistance was 
measured from the steady-state responses to a series of hyperpolarizing and subthreshold 
depolarizing current steps (duration 1.0 s, amplitude −200 to 100 pA, 50 pA steps), as the 
slope of a linear least-squares fit to the resulting voltage–current relationship. Current 
threshold for action potentials (APs) was defined as the magnitude of current step that 
produced at least one AP. Voltage threshold (in mV) for APs was defined as the point when 
dV/dt exceeded 10% of its maximum value, relative to a dV/dt baseline measured 2 ms 
before the AP peak, which was measured as the maximum membrane potential reached after 
threshold. All sEPSC recordings were filtered at 2 kHZ and digitized at 10 kHZ while all 
other recordings were filtered at 4 kHZ and digitized at 10 kHZ. For sEPSC recordings, 
Gabazine (Tocris, Bristol, UK; 10 or 25 μM) was added to the ACSF but blockers were not 
added to the ACSF for other recordings. Cells were allowed to equilibrate for 3–5 min prior 
to the onset of recordings for sEPSC. Resting membrane potential, series resistance, and 
input resistance were collected prior to the onset of sEPSC recordings. Means for amplitude 
and frequency were collected and analyzed for sEPSC recordings using custom MATLAB 
(MathWorks, Natick, MA) analysis routines. Spontaneously firing SOM+ neurons have been 
previously identified in the presubicular cortex and amygdala (Nassar et al., 2015; Wilson et 
al., 2019). We detected spontaneously firing SOM+ neurons (total = 14), but excluded them 
from analysis due to variable waveforms, significant rundown at higher current injections 
and instability of leak currents. Thus, the fidelity of the recordings could not be guaranteed. 
To be confident that the cells we recorded were indeed PVIN and SOM+ neurons, we 
conducted principal component analysis (PCA). Similar to Hu et al. (2013), we used 4 
electrophysiological parameters (action potential half-width, slow afterhyperpolarization, 
fast afterhyperpolarization, and spike frequency adaptation). This generated 3 main clusters 
of cells (cluster 1 was predominately SOM+ neurons, cluster 2 was predominately PVINs 
and cluster 3 was a mix of both cell types), which is similar to Nassar et al. (2015). For each 
cluster identified we further grouped the individual cell types into sub-clusters and 
conducted t tests on various electrophysiological variables. These comparisons resulted in 
significant differences between PVIN and SOM+ neurons, the most consistent of which was 
a difference in input resistance. Therefore, we are confident that the cells we have identified 
as PVIN and SOM+ neurons are correct.
QUANTIFICATION AND STATISTICAL ANALYSES
Power was set at 0.80, alpha of 0.05. For EPSCs, a priori power analysis was based off of the 
work of Zhang et al. (Zhang et al., 2015). For all other data, power analysis was completed 
post hoc. Sex was not included as a variable for power analysis as we did not initially 
compare males and females. We conducted separate power analysis for behavioral and 
electrophysiological data but did not conduct power analysis for every neuronal property that 
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we report. All data were first analyzed for normality and outliers using the D’Agostino-
Pearson normality test and the ROUT method with Q set to 1% in Prism (GraphPad 
Software, San Diego, CA). Two-way repeated-measures ANOVA was used for behavioral 
and FI curve analysis. Unpaired t tests or Mann-Whitney U tests were used for excitability 
and sEPSC data. Sidak’s multiple comparisons test was used for all multiple comparisons. 
Cells that exhibited series resistance >35 mOhm were excluded from analysis. For sEPSC, 
cells that had greater than 15% change in series resistance from baseline to the end of 
recording were removed from further analysis. Power and sample size were calculated using 
GPower (Heinrich-Heine-Universität, Düsseldorf, Germany).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Nerve injury enhances excitability of prelimbic PV+ neurons in male mice
• Nerve injury reduces EPSC frequency in prelimbic SOM+ neurons in female 
mice
• These changes to PV+ and SOM+ neurons are laminar specific
• Nerve injury does not affect PV+ or SOM+ neurons in infralimbic cortex
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Figure 1. SNI Increases PV Excitability in PL Cortex of Male, but Not Female, Mice
(A) Mechanical allodynia at baseline and post-operative day 7 (POD7) measured in male 
and female sham and SNI mice. Two-way repeated-measures ANOVA: interaction, F(1, 59) 
= 26.87, p < 0.0001; injury, F(1, 59) = 10.11, p = 0.0024; time, F(1, 59) = 60.31, p < 0.0001. 
Sidak post hoc tests revealed no significant differences between males and females at 
baseline and POD7. *p < 0.05; **p < 0.0001.
(B) Fluorescent confocal 10× image displaying distribution of PV-tdTomato neurons 
(PVINs) in the PL cortex (D, dorsal; V, ventral; M, medial; L, lateral).
(C) Representative images of a PVIN recording in PL cortex at 4× (left) and 60× (right).
(D and E) Example traces of action potential (AP) firing (D) and mean (±SEM) number of 
APs elicited in response to increasing step current from male and female sham mice (E) 
(two-way ANOVA: interaction, F(12, 408) = 5.00, p < 0.0001; sex, F(1, 34) = 1.34, p = 0.01; 
current, F(12, 408) = 108.9, p < 0.0001; *p < 0.05, Sidak post hoc test).
(F) Raw data and boxplot representation for input resistance versus normalized soma 
location for total (left: Mann-Whitney U = 90, n1 = 20, n2 = 16, p = 0.03), L2/3 (middle: 
t(12) = 0.27, p = 0.79), and L5 (right: t(20) = 2.35, p = 0.03) PVINs from sham males (total, 
n = 20 neurons; 9 mice) and females (total, n = 16 neurons; 6 mice). *p < 0.05.
(G and H) Example traces of AP firing (G) and mean (±SEM) number of APs elicited from 
male sham and SNI mice (H) (two-way ANOVA: interaction, F(12, 432) = 5.03, p < 0.0001; 
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injury, F(1, 36) = 4.49, p = 0.04; current, F(12, 432) = 143.5, p < 0.0001; *p < 0.05, Sidak 
post hoc test).
(I) Input resistance versus normalized soma location for total (left: Mann-Whitney U = 123, 
n1 = 18, n2 = 20, p = 0.10), L2/3 (middle: t(11) = 0.15, p = 0.89), and L5 (right: t(23) = 2.10, 
p = 0.05) PVINs from male sham (total, n = 20 neurons; 9 mice) and SNI (total, n = 18 
neurons; 6 mice). *p = 0.05.
(J and K) Example traces of AP firing (J) and mean (±SEM) number of APs elicited from 
female sham and SNI mice (K) (two-way ANOVA: interaction, F(12, 444) = 0.13, p = 0.99; 
injury, F(1, 37) = 0.04, p = 0.87; current, F(12, 444) = 128.1, p < 0.0001).
(L) Input resistance versus normalized soma location for total (t(37) = 0.31, p = 0.76), L2/3 
(t(16) = 0.71, p = 0.49), and L5 (Mann-Whitney U = 39, n1 = 13, n2 = 8, p = 0.37) PVINs 
from female sham (total, n = 16 neurons; 6 mice) and SNI (total, n = 22 neurons; 7 mice). 
Plus symbol indicates outlier in MATLAB.
Data represent mean ± SEM.
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Figure 2. SNI Reduces sEPSCs in L5 PL PVINs from Male Mice Only
(A–D) Sample sEPSC traces (A); sEPSC amplitude (B), t(20) = 1.19, p = 0.23; sESPC 
frequency (C), t(20) = 4.73, **p = 0.0001; and mean cumulative distribution curves (D) (top, 
amplitude; bottom, inter-EPSC interval) for male (n = 12 neurons; 5 mice) and female (n = 
13 neurons; 5 mice) sham mice.
(E–H) Sample sEPSC traces (E); sEPSC amplitude (F), t(21) = 1.17, p = 0.26; sESPC 
frequency (G), t(22) = 1.58, p = 0.06); and mean cumulative distribution curves
(H) for male sham (n = 12 neurons; 5 mice) and SNI (n = 12 neurons; 5 mice).
(I–L) Sample sEPSC traces (I); sEPSC amplitude (J), t(22) = 0.98, p = 0.34; sESPC 
frequency (K), t(22) = 0.83, p = 0.41; and mean cumulative distribution curves (L) for 
female sham (n = 13 neurons; 5 mice) and SNI (n = 11 neurons; 4 mice). Data represent 
mean ± SEM.
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Figure 3. SNI Decreases Excitability of SOM Neurons in PL Cortex
(A) Mechanical allodynia at baseline and post-operative day 7 (POD7) measured in male 
and female sham and SNI mice. Two-way repeated-measures ANOVA: interaction, F(1, 63) 
= 20.39, p < 0.0001; treatment, F(1, 63) = 14.25, p = 0.0004; time, F(1, 63) = 60.29, p < 
0.0001. Sidak post hoc tests revealed no significant differences between males and females 
at baseline and POD7. *p < 0.05; **p < 0.0001.
(B) Example fluorescent confocal 10× image of a brain slice displaying distribution of 
SOM-tdTomato (SOM) neurons in the PL cortex.
(C) Representative images of a SOM neuron recording in PL cortex at 4× (left) and 60× 
(right).
(D and E) Example traces of action potential (AP) firing (D) and mean (±SEM) number of 
APs elicited in response to increasing step current from sham male and female mice (E) 
(two-way ANOVA: interaction, F(12, 420) = 0.52, p = 0.90; sex, F(1, 35) = 1.76, p = 0.19; 
current, F(12, 420) = 92.62, p < 0.0001).
(F) Raw data and boxplots representation for input resistance versus normalized soma 
location for total (Mann-Whitney U = 144, n1 = 19, n2 = 17, p = 0.59), L2/3 (t(15) = 0.11, p 
= 0.91), and L5 t(15) = 0.62, p = 0.54) SOM neurons from sham females (total, n = 17 
neurons; 8 mice) and males (total, n = 18 neurons; 7 mice).
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(G and H) Example traces of AP firing (G) and mean (±SEM) number of APs elicited from 
male sham and SNI mice (H) (two-way ANOVA: interaction, F(12, 408) = 1.03, p = 0.42; 
injury, F(1, 34) = 2.46, p = 0.13; current injection, F(12, 408) = 78.76, p < 0.0001).
(I) Input resistance versus normalized soma location for total (t(34) = 1.83, p = 0.08), L2/3 
(t(15) = 1.64, p = 0.12), and L5 (Mann-Whitney U = 31, n1 = 8, n2 = 9, p = 0.67) SOM 
neurons from male sham (total, n = 20 neurons; 7 mice) and SNI (total, n = 18 neurons; 8 
mice).
(J and K) Example traces of AP firing (J) and mean (±SEM) number of APs elicited from 
female sham and SNI mice (K) (two-way ANOVA: interaction, F(12, 384) = 0.67, p = 0.78; 
injury, F(1, 32) = 0.16, p = 0.69; current, F(12, 384) = 95.05, p < 0.0001).
(L) Input resistance versus normalized soma location for total (Mann-Whitney U = 90, n1 = 
16, n2 = 17, p = 0.10), L2/3 (t(16) = 2.39, p = 0.03), and L5 (Mann-Whitney U = 27, n1 = 7, 
n2 = 8, p = 0.96) SOM neurons from female sham (total, n = 17 neurons; 8 mice) and SNI 
(total, n = 16 neurons; 7 mice). Plus symbol indicates outlier in MATLAB. *p < 0.05.
Data represent mean ± SEM.
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Figure 4. SNI Significantly Reduces Frequency of sEPSCs in L2/3 SOM Neurons of Female Mice
(A–D) Sample sEPSC traces (A), sEPSC amplitude (B) (t(13) = 1.20, p = 0.25), (C) sESPC 
frequency (t(12) = 0.87, p = 0.40), and mean cumulative distribution curves
(D) (top, amplitude; bottom, inter-EPSC interval) for L2/3 SOM neurons from sham males 
(n = 7 neurons; 3 mice) and females (n = 7 neurons; 4 mice).
(E–H) Sample sEPSC traces (E), sEPSC amplitude (F) (t(12) = 1.16, p = 0.27), sEPSC 
frequency (G) (t(13) = 0.81, p = 0.43), and mean cumulative distribution curves
(H) for L2/3 SOM neurons from male sham (n = 7 neurons; 3 mice) and SNI (n = 8 neurons; 
3 mice).
(I–L) Sample sEPSC traces (I), sEPSC amplitude (J) (t(14) = 0.28, p = 0.78), sEPSC 
frequency (K) (t(12) = 2.59, p = 0.02), and mean cumulative distribution curves (L) for L2/3 
SOM neurons from female sham (n = 7 neurons; 4 mice) and SNI (7 neurons; 5 mice). *p < 
0.05.
Data represent mean ± SEM.
Jones and Sheets Page 21

























Jones and Sheets Page 22
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Streptavidin Alexa Fluor 488 conjugate Invitrogen Ref# S32354; RRID: AB_2315383
Chemicals, Peptides, and Recombinant Proteins
SR95531 hydrobromide: Gabazine Tocris Cat # 1262; PubChem CID: 107896
Biocytin Tocris Cat # 3349; PubChem CID: 83814
QX314 chloride Tocris Cat # 2313; PubChem CID: 21462
HEPES Sigma-Aldrich Cat# H4034; PubChem CID: 23831
Potassium Gluconate Sigma-Aldrich Cat# P1847; PubChem CID: 16760467
Phosphocreatine disodium salt hydrate Sigma-Aldrich Cat# P7936; PubChem CID: 43835030
Magnesium Chloride Solution Sigma-Aldrich Cat# M1028; PubChem CID: 24584
Adenosine 5’-triphosphate disodium salt hydrate Sigma-Aldrich Cat# A6419; PubChem CID: 16218877
Guanosine 5’-triphosphate sodium salt hydrate Sigma-Aldrich Cat# G8877; PubChem CID: 13544577
Ascorbic Acid Sigma-Aldrich Cat# 5960; PubChem CID: 54670067
Cesium Methanesulfonate Sigma-Aldrich Cat# C1426; PubChem CID: 5148066
Ethylene glycol-bis(2-amino-ethylether)-N,N,N’,N’- 
tetraacetic acid (EGTA)
Sigma-Alrdich Cat# E3889; PubChem CID: 6207
Sodium Chloride Sigma-Aldrich Cat# S7653; PubChem CID: 5234
Sodium Bicarbonate Sigma-Aldrich Cat# S6014; PubChem CID: 24192197
Sodium Phosphate Monohydrate Monobasic Sigma-Aldrich Cat# S9638; PubChem CID: 516949
Potassium Chloride Solution Sigma-Aldrich Cat# 60137; PubChem SID: 24881800
D-glucose Sigma-Aldrich Cat# G8270; PubChem CID: 79025
Calcium Chloride Sigma-Aldrich Cat# 793639; PubChem CID: 24854
Choline Chloride Sigma-Aldrich Cat# C1879; PubChem CID: 19844489
Sodium Pyruvate Sigma-Aldrich Cat# P8574; PubChem CID: 10154024
Isoflurane USP Patterson Veterinary Cat # 07-893-2374; NDC: 14043-704-05
Normal Saline McKesson MFR# 37-6240
Experimental Models: Organisms/Strains
Mouse: SOM+: SST < tm2.1(cre)Zjh > /J Jackson Laboratories Stock # 013044; RRID: IMSR_JAX:013044
Mouse: PV+: B6;129P2-Pvalbtm1(cre)Arbr/J Jackson Laboratories Stock # 008069; RRID: IMSR_JAX:008069
Mouse: Ai14: B6.Cg-Gt(ROSA) 26Sortm14(CAG-
tdTomato)Hze/J
Jackson Laboratories Stock # 007914; RRID: IMSR_JAX:007914
Software and Algorithms
Prism version 7.04 GraphPad Software RRID: SCR_002798
MATLAB version R2018b MathWorks RRID: SCR_001622
GPower Heinrich-Heine- Universität RRID: SCR_013726
Adobe Illustrator CC 2018 Adobe Inc. RRID: SCR_010279
BioRender BioRender https://biorender.com
Other
Touch Test Sensory Evaluator: von Frey Filaments North Coast Medical Inc. Item #s: NC12775- 01, 02, 04, 05, 06, 08, 10,12
Nikon Confocal Nikon A1R
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REAGENT or RESOURCE SOURCE IDENTIFIER
Vibratome Leica VT1200S
Axon CNS Multiclamp Amplifier Molecular Devices 700B
Cool LED Scientifica pE-4000
Upright Microscope Olympus U-CMDPTS
Microscope Objectives Olympus 4X and 60X
Inline Heater and Monitor Warner Instruments Cat# 64–0102 and TC-324B
Anesthesia System Vetamac VAD Compact II
Feedback Rodent Warmer Stoelting X2
Micropipette Puller Sutter Instruments Flaming/Brown P-97
Borosilicate Glass Capillaries with Filaments Warner G150-F
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